Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.

Moradveisi L, Huibers M, Renner F, Arntz A.

J Behav Ther Exp Psychiatry. 2014 Mar;45(1):170-7. doi: 10.1016/j.jbtep.2013.10.003. Epub 2013 Oct 15.

PMID:
24172145
2.

The influence of patients' attributions of the immediate effects of treatment of depression on long-term effectiveness of behavioural activation and antidepressant medication.

Moradveisi L, Huibers MJ, Arntz A.

Behav Res Ther. 2015 Jun;69:83-92. doi: 10.1016/j.brat.2015.04.007. Epub 2015 Apr 14.

PMID:
25898343
3.

The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran.

Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A.

Behav Res Ther. 2013 Aug;51(8):499-506. doi: 10.1016/j.brat.2013.05.006. Epub 2013 May 30.

PMID:
23792179
4.

Patient treatment preference as a predictor of response and attrition in treatment for chronic depression.

Steidtmann D, Manber R, Arnow BA, Klein DN, Markowitz JC, Rothbaum BO, Thase ME, Kocsis JH.

Depress Anxiety. 2012 Oct;29(10):896-905. doi: 10.1002/da.21977. Epub 2012 Jul 5.

5.

Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial.

Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A.

Br J Psychiatry. 2013 Mar;202(3):204-11. doi: 10.1192/bjp.bp.112.113696. Epub 2013 Feb 7.

6.

Predicting response to cognitive therapy and interpersonal therapy, with or without antidepressant medication, for major depression: a pragmatic trial in routine practice.

Huibers MJ, van Breukelen G, Roelofs J, Hollon SD, Markowitz JC, van Os J, Arntz A, Peeters F.

J Affect Disord. 2014 Jan;152-154:146-54. doi: 10.1016/j.jad.2013.08.027. Epub 2013 Sep 3.

PMID:
24060588
7.

Patients' preferences in the treatment of depressive disorder in primary care.

van Schaik DJ, Klijn AF, van Hout HP, van Marwijk HW, Beekman AT, de Haan M, van Dyck R.

Gen Hosp Psychiatry. 2004 May-Jun;26(3):184-9. Review.

PMID:
15121346
8.

Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression.

Kwan BM, Dimidjian S, Rizvi SL.

Behav Res Ther. 2010 Aug;48(8):799-804. doi: 10.1016/j.brat.2010.04.003. Epub 2010 Apr 24.

9.

Attitudes and Preferences towards Self-help Treatments for Depression in Comparison to Psychotherapy and Antidepressant Medication.

Hanson K, Webb TL, Sheeran P, Turpin G.

Behav Cogn Psychother. 2016 Mar;44(2):129-39. doi: 10.1017/S1352465815000041. Epub 2015 Feb 20.

PMID:
25697236
10.

Treatment preferences in patients with first episode depression.

Houle J, Villaggi B, Beaulieu MD, Lespérance F, Rondeau G, Lambert J.

J Affect Disord. 2013 May;147(1-3):94-100. doi: 10.1016/j.jad.2012.10.016. Epub 2012 Nov 17.

PMID:
23167975
11.

Continuity is the main challenge in treating major depressive disorder in psychiatric care.

Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET.

J Clin Psychiatry. 2005 Feb;66(2):220-7.

PMID:
15705008
12.

Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.

Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, Young PR, Gallop R.

JAMA Psychiatry. 2014 Oct;71(10):1157-64. doi: 10.1001/jamapsychiatry.2014.1054. Erratum in: JAMA Psychiatry. 2016 Jun 1;73(6):639-40.

13.

Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.

van Calker D, Zobel I, Dykierek P, Deimel CM, Kech S, Lieb K, Berger M, Schramm E.

J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

PMID:
18849079
14.

Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials.

Bortolotti B, Menchetti M, Bellini F, Montaguti MB, Berardi D.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):293-302. doi: 10.1016/j.genhosppsych.2008.04.001. Review.

PMID:
18585531
15.

Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K.

J Clin Psychiatry. 2012 Jan;73(1):66-73. doi: 10.4088/JCP.11m06831. Epub 2011 Nov 29.

PMID:
22152401
16.

The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.

Wu CH, Erickson SR, Piette JD, Balkrishnan R.

Res Social Adm Pharm. 2012 May-Jun;8(3):193-205. doi: 10.1016/j.sapharm.2011.04.002. Epub 2011 Sep 28.

PMID:
21955808
17.

Psychotherapy and pharmacotherapy in depression.

Powers RH, Kniesner TJ, Croghan TW.

J Ment Health Policy Econ. 2002 Dec;5(4):153-61.

PMID:
14578549
18.

Depressive personality and treatment outcome in major depressive disorder.

Ryder AG, Quilty LC, Vachon DD, Bagby RM.

J Pers Disord. 2010 Jun;24(3):392-404. doi: 10.1521/pedi.2010.24.3.392.

PMID:
20545502
19.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
20.

Do general practitioners' attitudes towards depression predict their clinical behaviour?

Dowrick C, Gask L, Perry R, Dixon C, Usherwood T.

Psychol Med. 2000 Mar;30(2):413-9.

PMID:
10824661

Supplemental Content

Support Center